Nadim Ahmed Bristol Myers Squibb CO (BMY) insider trading activity

BMY Quotes by TradingView

Nadim Ahmed is EVP and President, Hematology of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 38,889 shares of BMY, which is worth approximately $2.33 Million. The most recent transaction as insider was on Dec 31, 2020, when has been sold 7,660 shares (Common Stock, $0.10 par value) at a price of $62.03 per share, resulting in proceeds of $475,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.9K
0% 3M change
0% 12M change
Total Value Held $2.33 Million

NADIM AHMED Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
SELL
Payment of exercise price or tax liability
$475,150 $62.03 p/Share
7,660 Reduced 16.46%
38,889 Common Stock, $0.10 pa...
Dec 31 2020
BUY
Exercise of conversion of derivative security
-
14,946 Added 24.3%
46,549 Common Stock, $0.10 pa...
Dec 02 2020
SELL
Payment of exercise price or tax liability
$210,168 $62.18 p/Share
3,380 Reduced 9.66%
31,603 Common Stock, $0.10 pa...
Dec 02 2020
BUY
Exercise of conversion of derivative security
-
6,594 Added 15.86%
34,983 Common Stock, $0.10 pa...
Oct 30 2020
SELL
Payment of exercise price or tax liability
$133,909 $58.45 p/Share
2,291 Reduced 7.47%
28,389 Common Stock, $0.10 pa...
Oct 30 2020
BUY
Exercise of conversion of derivative security
-
4,650 Added 13.16%
30,680 Common Stock, $0.10 pa...
May 01 2020
SELL
Payment of exercise price or tax liability
$86,353 $60.26 p/Share
1,433 Reduced 5.22%
26,030 Common Stock, $0.10 pa...
May 01 2020
BUY
Exercise of conversion of derivative security
-
2,908 Added 9.57%
27,463 Common Stock, $0.10 pa...
Mar 01 2020
SELL
Payment of exercise price or tax liability
$500,415 $59.06 p/Share
8,473 Reduced 25.65%
24,555 Common Stock, $0.10 pa...
Mar 01 2020
BUY
Exercise of conversion of derivative security
-
17,204 Added 34.25%
33,028 Common Stock, $0.10 pa...
Feb 04 2020
SELL
Payment of exercise price or tax liability
$68,855 $64.29 p/Share
1,071 Reduced 6.34%
15,824 Common Stock, $0.10 pa...
Feb 04 2020
BUY
Exercise of conversion of derivative security
-
2,076 Added 10.94%
16,895 Common Stock, $0.10 pa...
Nov 20 2019
BUY
Grant, award, or other acquisition
-
14,819 Added 50.0%
14,819 Common Stock, $0.10 pa...

Also insider at

CGEM
Cullinan Oncology, Inc. Healthcare
President and CEO
NA

Nadim Ahmed

EVP and President, Hematology
New York, NY

Track Institutional and Insider Activities on BMY

Follow BRISTOL MYERS SQUIBB CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

News

Receive news related to BRISTOL MYERS SQUIBB CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMY